SCHEMBL8444367

SCHEMBL8444367

Cc1nccn1CCCCCNCc1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 2/20 0.47
POLB P06746 2/20 0.47
KMT2A Q03164 2/20 0.47
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
KDM4E B2RXH2 1/20 0.44
THRB P10828 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 3/20 0.44
TP53 P04637 1/20 0.44
HRH4 Q9H3N8 2/20 0.43
HRH3 Q9Y5N1 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 1/20 0.42
MITF O75030 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8443179 0.95 ALDH1A1 (0.50) CHRM2SMN1; SMN2ALDH1A1POLBKMT2A
SCHEMBL7873768 0.87 MAOA (0.54) CHRM2ALDH1A1POLBKMT2ACA12
SCHEMBL7868642 0.83 CA12 (0.48) ALDH1A1POLBKMT2ACA12CA1
SCHEMBL14416035 0.81 KMT2A (0.51) CHRM2ALDH1A1POLBKMT2ACA12
SCHEMBL8446096 0.80 SMN1; SMN2 (0.51) CHRM2SMN1; SMN2ALDH1A1POLBKDM4E
SCHEMBL8445854 0.79 SMN1; SMN2 (0.47) CHRM2SMN1; SMN2POLBKDM4ETHRB
SCHEMBL8446894 0.78 HPGD (0.55) SMN1; SMN2ALDH1A1KMT2ATP53MEN1
Hydrochloric Acid SCHEMBL8446885 0.78 POLB (0.46) CHRM2SMN1; SMN2POLBKDM4ETHRB
SCHEMBL7875320 0.76 DRD4 (0.60) ALDH1A1POLBKMT2ACA12CA1
SCHEMBL8445718 0.76 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1POLBKMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0618907-B1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS BRITISH TECH GROUP INT (GB) 1999-04-28 EP disclosed
US-5547972-A 1-(ARLALKYLAMINOALKYL) IMIDAZOLE DERIVATIVES THE BOOTS COMPANY PLC (GB) 1996-08-20 US disclosed
WO-1995022327-A1 USE OF 1-(ARYLALKYLAMINOALKYL) IMIDAZOLES FOR TREATING NEUROLOGICAL DAMAGE KNOLL AG (DE) 1995-08-24 WO disclosed
EP-0618907-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS Knoll AG (DE) 1994-10-12 EP disclosed
WO-1993013075-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS THE BOOTS COMPANY PLC (GB) 1993-07-08 WO disclosed